Market Overview

Morning Market Movers

Related CYTR
Aldoxorubicin Continues To Demonstrate Positive Clinical Activity In Phase 2 Glioblastoma Trial
Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views
Related BGMD
Mid-Day Market Update: Thursday's Movers, China, Tesla And More
Stocks Hitting 52-Week Lows

CytRx (NASDAQ: CYTR) rose 68.20% to $4.02 on positive Phase 2B data.

BG Medicine (NASDAQ: BGMD) moved up 41.67% to $1.53 after the company confirmed final determination by CMS of 2014 reimbursement for BGM galectin-3 test.

LiveDeal (NASDAQ: LIVE) shares jumped 21.34% to $3.98 after the company announced the launch of in Los Angeles.

NanoString Technologies (NASDAQ: NSTG) jumped 17.30% to $16.48 as the company announced adoption of the Prosigna Breast Cancer Assay by leading US clinical laboratories and cancer centers.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (CYTR + BGMD)

Get Benzinga's Newsletters